U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07795762) titled 'Eplerenone and IOP in Healthy Adults' on Aug. 26.
Brief Summary: The goal of this clinical trial is to determine whether eplerenone lowers eye pressure in healthy adults. Eplerenone is a medication approved by the U.S. Food and Drug Administration for other medical conditions. Researchers will compare eplerenone with placebo (a substance containing no active drug) to determine whether eplerenone affects intraocular pressure (IOP). Participants will receive both eplerenone and placebo during different study periods and will have their eye pressure measured throughout the study. Blood pressure, kidney function, and potassium levels wi...